2024-04-01 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 07409682 2024-04-01 2025-03-31 07409682 bus:FullAccounts 2024-04-01 2025-03-31 07409682 bus:FRS102 2024-04-01 2025-03-31 07409682 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07409682 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07409682 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07409682 2024-04-01 2025-03-31 07409682 2025-03-31 07409682 bus:RegisteredOffice 2024-04-01 2025-03-31 07409682 core:WithinOneYear 2025-03-31 07409682 core:AfterOneYear 2025-03-31 07409682 1 2024-04-01 2025-03-31 07409682 bus:Director1 2024-04-01 2025-03-31 07409682 bus:Director1 2025-03-31 07409682 bus:Director1 2023-04-01 2024-03-31 07409682 2023-04-01 07409682 2023-04-01 2024-03-31 07409682 2024-03-31 07409682 core:WithinOneYear 2024-03-31 07409682 core:AfterOneYear 2024-03-31 07409682 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 07409682 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 07409682 bus:OrdinaryShareClass1 2025-03-31 07409682 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 07409682 bus:OrdinaryShareClass1 2024-03-31 07409682 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 07409682 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 07409682 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 07409682 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07409682 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 07409682 core:Non-currentFinancialInstruments 2025-03-31 07409682 core:Non-currentFinancialInstruments 2024-03-31 07409682 core:ShareCapital 2025-03-31 07409682 core:ShareCapital 2024-03-31 07409682 core:RetainedEarningsAccumulatedLosses 2025-03-31 07409682 core:RetainedEarningsAccumulatedLosses 2024-03-31 07409682 dpl:Item1 2024-04-01 07409682 dpl:Item1 2025-03-31 07409682 dpl:Item1 2023-04-01 07409682 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07409682
England and Wales

 

 

 

LEIBERT PHARMA SERVICES LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 April 2024

End date: 31 March 2025
Director Adrian Leibert
Registered Number 07409682
Registered Office 81 Dovecote Lane
Beeston
Nottingham
NG9 1JG
1
Director's report and financial statements
The director presents his/her/their annual report and the financial statements for the year ended 31 March 2025
Director
The director who served the company throughout the year was as follows:
Adrian Leibert
Statement of director's responsibilities
The director is responsible for preparing the directors’ report and the financial statements in accordance with applicable law and regulation.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to
  • select suitable accounting policies and then apply them consistently
  • make judgments and accounting estimates that are reasonable and prudent
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business


The director is responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

On behalf of the board.


----------------------------------
Adrian Leibert
Director

Date approved: 30 December 2025
2
 
 
Notes
 
2025
£
  2024
£
Current assets      
Debtors 3 9,897    2 
Cash at bank and in hand   31,558 
9,897    31,560 
Creditors: amount falling due within one year (250)   (21,647)
Net current assets 9,647    9,913 
 
Total assets less current liabilities 9,647    9,913 
Net assets 9,647    9,913 
 

Capital and reserves
     
Called up share capital 4 2    2 
Profit and loss account 9,645    9,911 
Shareholders' funds 9,647    9,913 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 30 December 2025 and were signed by:


-------------------------------
Adrian Leibert
Director
3
General Information
LEIBERT PHARMA SERVICES LTD is a private company, limited by shares, registered in England and Wales, registration number 07409682, registration address 81 Dovecote Lane , Beeston, Nottingham , NG9 1JG.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Debtors: amounts falling due within one year

2025
£
  2024
£
Other Debtors 5,075    2 
PAYE & Social Security 3,616   
8,691    2 

3.

Debtors: amounts falling due after one year

2025
£
  2024
£
Prepayments 1,206   
1,206   

4.

Share Capital

Authorised
2 Class A shares of £1.00 each
Allotted, called up and fully paid
2025
£
  2024
£
2 Class A shares of £1.00 each  
 

4